| Cover | Dec. 15, 2021 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Dec. 15, 2021 |
| Entity File Number | 001-40544 |
| Entity Registrant Name | AEROVATE THERAPEUTICS, INC. |
| Entity Central Index Key | 0001798749 |
| Entity Tax Identification Number | 83-1377888 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | Aerovate Therapeutics, Inc. |
| Entity Address, Address Line Two | 930 Winter Street |
| Entity Address, City or Town | Suite M-500 |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02451 |
| City Area Code | (617) |
| Local Phone Number | 443-2400 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | AVTE |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
